S Kara, G Lazovic, F Chohan… - … in Vaccines and …, 2022 - journals.sagepub.com
Background and Aims: The peak of the third wave of COVID-19 infection was in the summer (August–September) of 2021, dominated by the Delta variant. Florida was the epicenter of …
CM Shover, P Yan, NJ Jackson, RG Buhr… - Journal of Cannabis …, 2022 - Springer
Background While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated …
Objective Despite advancement in vaccines and treatments for COVID-19 over the past 2 years, many concerns remain about reinfection and waning immunity against COVID-19 and …
A Morozov, V Nirca, A Victorova, S Poppert… - Viruses, 2022 - mdpi.com
Since the onset of the COVID-19 pandemic, no viral genome sequences of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been documented from the …
G Sampogna, M Di Vincenzo, B Della Rocca… - Rivista di …, 2022 - rivistadipsichiatria.it
A paradox of the modern world is represented by the increasing rate of comorbidities, although the life expectancy is increasing worldwide, the number of disease-free years is not …
Abstract Background and Aims Cannabis use is increasingly common among pregnant individuals and might be a risk factor for severe acute respiratory syndrome coronavirus 2 …
Human coronaviruses have neuroinvasive and neurotropic abilities that might explain psychiatric outcomes in affected patients. We hypothesized that delirium might be the sole …
R Damiescu, M Banerjee, NW Paul, T Efferth - Trends in Pharmacological …, 2022 - cell.com
COVID-19 has put vaccine efficacy under a spotlight. However, the reluctance of people to be vaccinated has postponed the end of the COVID-19 pandemic. Currently, opioid vaccines …
Background Population-level statistics on pandemic-related change in substance use can obscure patterns of use (eg, polysubstance use) within individuals. This longitudinal study …